drugset / Trial / NCT01736891
Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations
Phase 3
Completed
268 enrolled
Chongqing Fortune Pharmaceutical Co., Ltd.
Beijing Bionovo Medicine Development Co., Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the efficacy, tolerability, and safety of rasagiline compared to placebo in PD patients with motor fluctuations on levodopa therapy.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rasagiline | Small molecule | 1 mg | Oral |